These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23612727)

  • 1. Primary resistance phenomena to oncolytic measles vaccine viruses.
    Noll M; Berchtold S; Lampe J; Malek NP; Bitzer M; Lauer UM
    Int J Oncol; 2013 Jul; 43(1):103-12. PubMed ID: 23612727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis.
    Lampe J; Bossow S; Weiland T; Smirnow I; Lehmann R; Neubert W; Bitzer M; Lauer UM
    Gene Ther; 2013 Nov; 20(11):1033-41. PubMed ID: 23719065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase.
    Hartkopf AD; Bossow S; Lampe J; Zimmermann M; Taran FA; Wallwiener D; Fehm T; Bitzer M; Lauer UM
    Gynecol Oncol; 2013 Aug; 130(2):362-8. PubMed ID: 23676551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma.
    Lange S; Lampe J; Bossow S; Zimmermann M; Neubert W; Bitzer M; Lauer UM
    Hum Gene Ther; 2013 May; 24(5):554-64. PubMed ID: 23550539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsed versus continuous application of the prodrug 5-fluorocytosine to enhance the oncolytic effectiveness of a measles vaccine virus armed with a suicide gene.
    Yurttas C; Berchtold S; Malek NP; Bitzer M; Lauer UM
    Hum Gene Ther Clin Dev; 2014 Jun; 25(2):85-96. PubMed ID: 24933569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis.
    Berchtold S; Lampe J; Weiland T; Smirnow I; Schleicher S; Handgretinger R; Kopp HG; Reiser J; Stubenrauch F; Mayer N; Malek NP; Bitzer M; Lauer UM
    J Virol; 2013 Mar; 87(6):3484-501. PubMed ID: 23302892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing and Overcoming Resistance Phenomena against a Genetically Modified Vaccinia Virus in Selected Cancer Cell Lines.
    Berchtold S; Beil J; Raff C; Smirnow I; Schell M; D'Alvise J; Gross S; Lauer UM
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced killing of therapy-induced senescent tumor cells by oncolytic measles vaccine viruses.
    Weiland T; Lampe J; Essmann F; Venturelli S; Berger A; Bossow S; Berchtold S; Schulze-Osthoff K; Lauer UM; Bitzer M
    Int J Cancer; 2014 Jan; 134(1):235-43. PubMed ID: 23797800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human precision-cut liver tumor slices as a tumor patient-individual predictive test system for oncolytic measles vaccine viruses.
    Zimmermann M; Armeanu S; Smirnow I; Kupka S; Wagner S; Wehrmann M; Rots MG; Groothuis GM; Weiss TS; Königsrainer A; Gregor M; Bitzer M; Lauer UM
    Int J Oncol; 2009 May; 34(5):1247-56. PubMed ID: 19360338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus.
    Scheubeck G; Berchtold S; Smirnow I; Schenk A; Beil J; Lauer UM
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31284426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Sensitivity of Neuroendocrine Neoplasms to an Armed Oncolytic Measles Vaccine Virus.
    Scheicher NV; Berchtold S; Beil J; Smirnow I; Schenk A; Lauer UM
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy.
    Kurokawa C; Iankov ID; Anderson SK; Aderca I; Leontovich AA; Maurer MJ; Oberg AL; Schroeder MA; Giannini C; Greiner SM; Becker MA; Thompson EA; Haluska P; Jentoft ME; Parney IF; Weroha SJ; Jen J; Sarkaria JN; Galanis E
    J Natl Cancer Inst; 2018 Oct; 110(10):1123-1132. PubMed ID: 29788332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic measles virus strains as novel anticancer agents.
    Msaouel P; Opyrchal M; Domingo Musibay E; Galanis E
    Expert Opin Biol Ther; 2013 Apr; 13(4):483-502. PubMed ID: 23289598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of oncolytic measles virus: promises and challenges.
    Galanis E
    Clin Pharmacol Ther; 2010 Nov; 88(5):620-5. PubMed ID: 20881957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic measles virus as a novel therapy for malignant peripheral nerve sheath tumors.
    Deyle DR; Escobar DZ; Peng KW; Babovic-Vuksanovic D
    Gene; 2015 Jul; 565(1):140-5. PubMed ID: 25843626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of measles virus oncolytic immunotherapy.
    Pidelaserra-Martí G; Engeland CE
    Cytokine Growth Factor Rev; 2020 Dec; 56():28-38. PubMed ID: 32660751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
    Ishida D; Nawa A; Tanino T; Goshima F; Luo CH; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Tsurumi T; Nishiyama Y; Kikkawa F
    Cancer Lett; 2010 Feb; 288(1):17-27. PubMed ID: 19604626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental therapy of allogeneic solid tumors induced in athymic mice with suicide gene-transducing replication-competent foamy virus vectors.
    Heinkelein M; Hoffmann U; Lücke M; Imrich H; Müller JG; Meixensberger J; Westphahl M; Kretschmer A; Rethwilm A
    Cancer Gene Ther; 2005 Dec; 12(12):947-53. PubMed ID: 15905857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles virus as an oncolytic vector platform.
    Blechacz B; Russell SJ
    Curr Gene Ther; 2008 Jun; 8(3):162-75. PubMed ID: 18537591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation in Oncolytic Measles Virotherapy.
    Dietz L; Engeland CE
    Methods Mol Biol; 2020; 2058():111-126. PubMed ID: 31486034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.